N/A
N=831
Understanding Factors in Decision Making for Children With Medical Complexity
Multiple Chronic Conditions · Children With Medical Complexity
Bottom Line
View on ClinicalTrials.gov: NCT05913206 ↗Enrolled (actual)
831
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Decision Readiness — 77.3; 79.1; 79.1; 78.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ambiguity (Behavioral); Complexity (Behavioral); Normalizing language (Behavioral); Narrative (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Utah
- Primary completion
- Aug 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Decision Readiness |
77.3; 79.1; 79.1; 78.5; 82.3; 80.5 | — |
| SECONDARY Decisional Conflict Scale |
30.7; 36.5; 32.9; 28.1; 26.0; 31.3 | — |
| SECONDARY Decision Intent for Treatment |
7; 9; 9; 8; 5; 10 | — |
| SECONDARY Knowledge |
0.9; 0.8; 0.8; 0.8; 0.8; 0.8 | — |
Summary
The goal of this clinical trial is to compare different strategies to communicate around potential risks and benefits related to treatment decision making in parents/adult caregivers of children with medical complexity. The objective of this study is to identify the most effective ways to communicate decision-related risks and benefits to improve the quality of caregiver decision making for children with medical complexity.
Participants will view a video of a simulated clinic visit and related medical information and complete a survey about their experiences. Researchers will compare participant survey responses to see if decision quality changes based on the information reviewed by the participant.
Eligibility Criteria
Inclusion Criteria
- Adult caregiver of a child with medical complexity
- English- or Spanish-speaking
Exclusion Criteria
- Child is diagnosed with neuromuscular scoliosis but has not yet made a decision about whether to undergo spinal fusion.
Data sourced from ClinicalTrials.gov (NCT05913206). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.